Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.

CONCLUSION: The short-term outcome of tacrolimus in steroid-refractory acute severe ulcerative colitis was beneficial, and side effects were rare. In all, tacrolimus therapy appears to be a viable option for short-term treatment of steroid-refractory acute severe ulcerative colitis besides ciclosporin and anti-tumor necrosis factor α treatment. PMID: 30983820 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30983820?dopt=Abstract

Source: World Journal of Gastroenterology : WJG - April 6, 2019 Category: Gastroenterology Authors: Hoffmann P, Wehling C, Krisam J, Pfeiffenberger J, Belling N, Gauss A Tags: World J Gastroenterol Source Type: research